Novo Nordisk A/S ADR (NVO)

Wall Street loves coming up with cute little phrases, whether that be “FANG” or the more recent Magnificent 7. However, Thornburg portfolio manager Nicholas Anderson…

7 A-Rated Biotech Stocks Worth Betting on in June

By Louis Navellier and the InvestorPlace Research Staff Jun 14, 2024

A-rated biotech stocks are highly coveted because they are at the forefront — or in the midst of — groundbreaking innovation.

3 Stocks to Buy as Ozempic Surges in Popularity

By Joey Frenette, InvestorPlace Contributor Jun 13, 2024

Ozempic has surged in popularity in recent years, but the best may be to come as innovators look to launch new drugs to meet hot demand.

The Safety Net Seven: 7 Stocks to Own for Unshakeable Returns

By Josh Enomoto, InvestorPlace Contributor Jun 10, 2024

Although they’re not necessarily the most exciting ideas, investors should turn to safe stocks to buy to manage the market’s ambiguity.

The 3 Most Undervalued Pharma Stocks to Buy in June 2024

By Larry Ramer, InvestorPlace Contributor Jun 6, 2024

These undervalued pharma stocks to buy are worth a look because even when the economy is struggling, consumers need key medicines.

Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential

By Vandita Jadeja Jun 5, 2024

If you have the patience and the ability to take a little risk, consider these three biotech stocks to buy since they can really pay off.

7 Biotech Stocks to Put on Your Breakthrough Radar

By Josh Enomoto, InvestorPlace Contributor May 27, 2024

For those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower. Let’s get some of…

3 Underappreciated Biotech Stocks to Buy Now: May 2024

By Terel Miles, InvestorPlace Contributor May 27, 2024

Vertex Pharmaceuticals (VRTX), United Therapeutics (UTHR), and Novo Nordisk (NVO) are the top 3 biotech stocks to buy in May 2024.

7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

By Josh Enomoto, InvestorPlace Contributor May 20, 2024

Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying prioritization. While the media focuses on attaining wealth, that doesn’t…

Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?

By Alex Sirois, InvestorPlace Contributor May 17, 2024

Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs

By Alex Sirois, InvestorPlace Contributor May 16, 2024

AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.

Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade

By Rich Duprey, InvestorPlace Contributor May 16, 2024

The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics.

Biotech Behemoths: 3 Giants Set to Dominate the Health Scene

By Joey Frenette, InvestorPlace Contributor May 14, 2024

The biotech behemoths stand out as compelling and exciting options for investors seeking steady long-term growth.

7 Stocks That Ordinary Investors Can’t Get Enough Of Right Now

By Josh Enomoto, InvestorPlace Contributor May 10, 2024

In an ecosystem where individuality is celebrated and groupthink is criticized, it may seem imprudent to target popular stocks among retail investors. However, putting minds…

Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare

By Josh Enomoto, InvestorPlace Contributor May 7, 2024

Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because…

3 Under-The-Radar Stocks That Could Be Worth Over $1 Trillion by 2030

By Omor Ibne Ehsan May 3, 2024

These under-the-radar stocks have the potential to reach a $1 trillion valuation by 2030 as they gain momentum in their respective industries.

NVO Stock Earnings: Novo Nordisk Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 2, 2024

NVO stock results show that Novo Nordisk beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Novo Nordisk A/S ADR (NVO)

3 Breakout Biotech Stocks on Track to Double by 2032

The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains

The Next 7 Trillion-Dollar Stocks to Buy: June 2024 Edition

NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novo Nordisk A/S ADR (NVO)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVO Stock Predictions, Articles, and Novo Nordisk A/S ADR News

Subscriber Sign in